Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy

Study ID: NCT07018739
Start Date: 2026-06
End Date: 2033-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Wharton's jelly-derived mesenchymal stem cells

0.9 % Normal Saline

Sponsor

Mahidol University

Source: clinicaltrials.gov

Share:
Add to list

Prophylactic PIPAC in Patients With High-risk Colorectal Cancer

Study ID: NCT06839092
Start Date: 2026-01
End Date: 2034-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

160

Intervention / Treatment

oxaliplatin-based PIPAC

Control (Standard treatment)

Sponsor

Jeremy Meyer

Source: clinicaltrials.gov

Share:
Add to list

A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerging Adults

Study ID: NCT07214831
Start Date: 2027-06-01
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Large language model-based chatbot brief alcohol intervention session

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Functional and Occupational Rehabilitation of Troops

Study ID: NCT06898866
Start Date: 2025-12
End Date: 2028-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

480

Intervention / Treatment
Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma

Study ID: NCT07223541
Start Date: 2025-12
End Date: 2031-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

72

Intervention / Treatment

Cemiplimab 350 MG Intravenous Solution

Fianlimab 1600 MG Intravenous Solution

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure

Study ID: NCT07220902
Start Date: 2026-01-01
End Date: 2034-07
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1240

Intervention / Treatment

Levetiracetam

magnesium sulfate

Sponsor

Nebraska Methodist Health System

Source: clinicaltrials.gov

Share:
Add to list

Analgesic Effect of TENS-WAA Combined With Tramadol Hydrochloride During Oocyte Retrieval Surgery

Study ID: NCT07212127
Start Date: 2025-11-08
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Transcutaneous Electrical Nerve Stimulation based on Wrist-Ankle Acupuncture theory（TENS-WAA)

Sponsor

First Affiliated Hospital of the Chinese People's Liberation Army Naval Medical University

Source: clinicaltrials.gov

Share:
Add to list

Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease

Study ID: NCT07215481
Start Date: 2025-12
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Shame Control (Baseline)

Standard of Care Deep Brain Stimulation

Illumina 3D Deep Brain Stimulation

Illumina 3D Deep Brain Stimulation Reduced Amplitude

Illumina 3D Deep Brain Stimulation Higher Amplitude

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Study ID: NCT07141771
Start Date: 2025-12-31
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Serplulimab

Fluzoparib

Topotecan/Irinotecan/Paclitaxel/Temozolomide

Etoposide/Carboplatin/Cisplatin

Lurbinectedin

Temozolomide

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting

Study ID: NCT07109375
Start Date: 2026-01
End Date: 2028-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment

pegunigalsidase alfa

Sponsor

Chiesi Italia

Source: clinicaltrials.gov

Share:
Add to list